Abstract
Lymphatic mapping continues to grow in utility both as a diagnostic aid and as a method for performing less morbid, potentially therapeutic lymphadenectomies. Its use in breast cancer has become the standard of care for staging and sentinel lymph node dissection is considered sufficiently therapeutic for low-volume axillary disease. Lymphatic mapping has re-emphasized the importance of adequate lymphatic staging both in terms of the amount of lymph nodes resected and the amount of each lymph node that is assessed. Going forward, these concepts continue to be adopted into other tumors, with active investigations ongoing in gastrointestinal cancers, head and neck cancers, and gynecologic cancers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
